By Jamie Lennox ( May 8, 2025, 6:38 PM BST) -- The Unified Patent Court on Thursday refused pharmaceuticals giant Boehringer Ingelheim's attempt to stop a rival from making a generic version of its lung disease medicine, ruling there is no risk of "imminent" patent infringement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.